You have 9 free searches left this month | for more free features.

Ranibizumab

Showing 1 - 25 of 689

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Ischemic Central Retinal Vein Occlusion With Macular Edema Trial in Qina (intravitreal injection of Ranibizumab,

Recruiting
  • Non-Ischemic Central Retinal Vein Occlusion With Macular Edema
  • intravitreal injection of Ranibizumab
  • +3 more
  • Qinā, Qena, Egypt
    Ahmed Ali Ahmed Amer
Mar 15, 2022

Diabetic Retinopathy, Postoperative Recurrent Vitreous Hemorrhage, Pars Plana Vitrectomy Trial in Tianjin (Ranibizumab

Recruiting
  • Diabetic Retinopathy
  • +3 more
  • Ranibizumab Injection
  • PPV
  • Tianjin, Tianjin, China
    Tianjin medical university eye hosipital
Aug 11, 2022

Age Related Macular Degeneration Trial in Nedlands (HLX04-O, ranibizumab)

Recruiting
  • Age Related Macular Degeneration
  • Nedlands, Western Australia, Australia
    Lions Eye Institute
Feb 7, 2022

Glaucoma, Neovascular Trial in Bangkok (intravitreal ranibizumab, Trabeculectomy with mitomycinC)

Completed
  • Glaucoma, Neovascular
  • intravitreal ranibizumab
  • Trabeculectomy with mitomycinC
  • Bangkok, Thailand
    Naris Kitnarong
Jul 12, 2021

Retinopathy of Prematurity Both Eyes Trial in Zagazig (Bevacizumab, Ranibizumab)

Recruiting
  • Retinopathy of Prematurity Both Eyes
  • Bevacizumab, Ranibizumab
  • Zagazig, Egypt
    Zagazig University
Aug 26, 2021

Wet Age-related Macular Degeneration Trial (Ranibizumab, SCT510A)

Not yet recruiting
  • Wet Age-related Macular Degeneration
  • (no location specified)
Jul 28, 2022

Age Related Macular Degeneration Trial in London (Ranibizumab, Aflibercept)

Completed
  • Age Related Macular Degeneration
  • London, UK, United Kingdom
    King's College Hospital NHS Foundation Trust
Apr 29, 2021

Diabetic Macular Edema, Macular Ischemia, Diabetic Retinopathy Trial in Cairo (Intravitreal ranibizumab, Intravitreal

Recruiting
  • Diabetic Macular Edema
  • +3 more
  • Intravitreal ranibizumab
  • Intravitreal bevacizumab
  • Cairo, Egypt
    Cairo University
Nov 26, 2021

Patients Treated With ranibizUmab for REtinal Vein Occlusion

Terminated
  • Retinal Vein Occlusion
    • Baltimore, Maryland
      Wilmer Eye Institute
    Oct 8, 2021

    Diabetic Macular Edema Trial in Giza (Lucentis alone group, Lucentis dexamethasone group)

    Completed
    • Diabetic Macular Edema
    • Lucentis alone group
    • Lucentis dexamethasone group
    • Giza, Cairo, Egypt
      Khaled G Abueleinen
    Feb 27, 2022

    Mild Non-proliferative Diabetic Retinopathy, Cataract Diabetic, Diabetic Retinopathy Trial in Shanghai (Ranibizumab Injection

    Recruiting
    • Mild Non-proliferative Diabetic Retinopathy
    • +2 more
    • Ranibizumab Injection [Lucentis]
    • Phacoemulsification
    • Shanghai, Shanghai, China
      Department of Ophthalmology, Ruijin Hospital Affiliated Medical,
    May 18, 2022

    Patients With Primary Nasal Pterygium Trial in Kota Bharu (intralesional ranibizumab)

    Completed
    • Patients With Primary Nasal Pterygium
    • intralesional ranibizumab
    • Kota Bharu, Kelantan, Malaysia
      Hospital Universiti Sains Malaysia
    May 6, 2021

    Von Hippel-Lindau Syndrome Trial run by the NEI (Ranibizumab, E10030)

    Completed
    • Von Hippel-Lindau Syndrome
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 21, 2021

    Pathological Myopic Choroidal Neovascularization Trial in BeiJing (601, Ranibizumab)

    Recruiting
    • Pathological Myopic Choroidal Neovascularization
    • BeiJing, China
      Peking Union Medical College Hospital
    Jun 4, 2021

    naïve Age-related Macular Degeneration Neovascular Type and

    Completed
    • Macular Degeneration
    • Data extraction from medical files
    • Brussels, Belgium
      CHU Brugmann
    Mar 7, 2022

    Lucentis® in Patients With Retinopathy of Prematurity

    Not yet recruiting
    • Retinopathy of Prematurity
    • Lucentis
    • (no location specified)
    Jun 28, 2022

    Reading Speed Improvements in Wet-AMD Patients After Ranibizumab

    Completed
    • Ophthalmopathy
    • Wet Macular Degeneration
      • (no location specified)
      Jul 20, 2021

      Radiation Retinopathy Trial in United States (0.5 mg ranibizumab, Targeted Retinal Photocoagulation (TRP))

      Completed
      • Radiation Retinopathy
      • 0.5 mg ranibizumab
      • Targeted Retinal Photocoagulation (TRP)
      • Dallas, Texas
      • +3 more
      Mar 24, 2021

      Neovascular Age-related Macular Degeneration Trial in United States (SUSVIMO (ranibizumab injection), LUCENTIS (ranibizumab

      Recruiting
      • Neovascular Age-related Macular Degeneration
      • SUSVIMO (ranibizumab injection)
      • LUCENTIS (ranibizumab injection)
      • Mesa, Arizona
      • +32 more
      Aug 2, 2022

      Age Related Macular Degeneration, Diabetic Macular Edema, Macular Edema Trial in Toronto (Intravitreal ranibizumab)

      Recruiting
      • Age Related Macular Degeneration
      • +3 more
      • Intravitreal ranibizumab
      • Toronto, Ontario, Canada
      • +1 more
      Apr 27, 2021

      Diabetic Macular Edema Trial in Cleveland, Mayfield Heights (Ranibizumab)

      Completed
      • Diabetic Macular Edema
      • Ranibizumab
      • Cleveland, Ohio
      • +1 more
      Oct 30, 2020

      Ophthalmopathy Trial in Asyut (Ranibizumab, triamcinolone acetate)

      Unknown status
      • Ophthalmopathy
      • Ranibizumab
      • triamcinolone acetate
      • Asyut, Egypt
        Wael
      Jul 2, 2020

      Proliferative Diabetic Retinopathy Trial in Beijing (preoperative intravitreal injections of ranibizumab or conbercept)

      Completed
      • Proliferative Diabetic Retinopathy
      • preoperative intravitreal injections of ranibizumab or conbercept
      • Beijing, Beijing, China
        Peking University People's Hospital
      Jun 7, 2022

      Diabetic Macular Edema, Hard Lipid Exudates Trial in United States (ranibizumab 0.3mg)

      Completed
      • Diabetic Macular Edema
      • Hard Lipid Exudates
      • ranibizumab 0.3mg
      • Huntington Beach, California
      • +3 more
      Jul 6, 2021

      Central Retinal Vein Occlusion Trial in Stockholm (Aflibercept, Ranibizumab)

      Completed
      • Central Retinal Vein Occlusion
      • Stockholm, Sweden
        St Eriks Eye Hospital
      Dec 3, 2020